NCT03887338

Brief Summary

The study examines if titration of Non-Invasive mechanical ventilation (NIV) settings during ongoing laryngoscopic visualization can improve the compliance of NIV in subjects with Amyotrophic Lateral Sclerosis (ALS). The study is a multicentre study between Norwegian National Advisory Unit on Long-term Mechanical Ventilation at the Thoracic Department, Haukeland University Hospital, Bergen, Norway and Centro Hospital Tras-os-Montes e Alto Douro, Vila Real, Portugal.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2019

Completed
6 days until next milestone

Study Start

First participant enrolled

March 21, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 22, 2019

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

March 2, 2021

Status Verified

March 1, 2021

Enrollment Period

2.8 years

First QC Date

March 15, 2019

Last Update Submit

March 1, 2021

Conditions

Keywords

Noninvasive VentilationLaryngoscopy

Outcome Measures

Primary Outcomes (5)

  • Apnoea-hypopnea index (AHI)

    Change in number of apnea and hypopnea events per hour of sleep

    Baseline, one and three months after the intervention.

  • Time of NIV use

    Change in median daily and average daily of hours, minutes

    Baseline, one and three months after the intervention.

  • NIV Leaks

    Change in median and 95%

    Baseline, one and three months after the intervention.

  • NIV time of use

    Change in % of time of use \> than 4 hours/day

    Baseline, one and three months after the intervention.

  • NIV compliance

    Change in number of interruptions, complains and ventilator adjustments

    Baseline, one and three months after the intervention.

Secondary Outcomes (2)

  • Night-time pulseoximeter

    Baseline, one and three months after the intervention.

  • Night-time capnography

    Baseline, one and three months after the intervention.

Study Arms (1)

NIV settings titration

OTHER

Transnasal Fiberoptic Laryngoscopy will be used during ongoing NIV setting titration. Aim is to titrate NIV setting to be more optimal for laryngeal responses.

Other: Transnasal Fiberoptic Laryngoscopy

Interventions

Use of Transnasal Fiberoptic Laryngoscopy during NIV titration to optimalize the NIV settings to laryngeal responses during the NIV treatment.

NIV settings titration

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed Amyotrophic Lateral Sclerosis (ALS) due to El Escorial criteria
  • Must have already established Non-invasive ventilation (NIV)

You may not qualify if:

  • Ages under 18 years
  • Unstable ischemic heart disease
  • Oncological disease
  • Ventilatory support dependency (more than 16h per day)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Norwegian National Advisory Unit on Long-term Mechanical Ventilation at Thoracic Department, Haukeland University Hospital

Bergen, Hordaland, 5021, Norway

Location

Centro Hospitalar Tras-os-Montes e Alto Douro

Vila Real, Portugal

Location

Related Publications (5)

  • Andersen T, Sandnes A, Brekka AK, Hilland M, Clemm H, Fondenes O, Tysnes OB, Heimdal JH, Halvorsen T, Vollsaeter M, Roksund OD. Laryngeal response patterns influence the efficacy of mechanical assisted cough in amyotrophic lateral sclerosis. Thorax. 2017 Mar;72(3):221-229. doi: 10.1136/thoraxjnl-2015-207555. Epub 2016 May 12.

    PMID: 27174631BACKGROUND
  • Andersen TM, Sandnes A, Fondenes O, Nilsen RM, Tysnes OB, Heimdal JH, Clemm HH, Halvorsen T, Vollsaeter M, Roksund OD. Laryngeal Responses to Mechanically Assisted Cough in Progressing Amyotrophic Lateral Sclerosis. Respir Care. 2018 May;63(5):538-549. doi: 10.4187/respcare.05924. Epub 2018 Apr 17.

    PMID: 29666294BACKGROUND
  • Andersen TM, Sandnes A, Fondenes O, Clemm H, Halvorsen T, Nilsen RM, Tysnes OB, Heimdal JH, Vollsaeter M, Roksund OD. Laryngoscopy Can Be a Valuable Tool for Unexpected Therapeutic Response in Noninvasive Respiratory Interventions. Respir Care. 2018 Nov;63(11):1459-1461. doi: 10.4187/respcare.06674. No abstract available.

    PMID: 30389835BACKGROUND
  • Conde B, Martins N, Brandao M, Pimenta AC, Winck JC. Upper Airway Video Endoscopy: Assessment of the response to positive pressure ventilation and mechanical in-exsufflation. Pulmonology. 2019 Sep-Oct;25(5):299-304. doi: 10.1016/j.pulmoe.2019.02.008. Epub 2019 Apr 16.

    PMID: 31000441BACKGROUND
  • Andersen TM, Halvorsen T, Fondenes O, Heimdal JH, Roksund OD, Vollsaeter M, Roksund OD. Larynx: The Complex Gateway to the Lungs. Respir Care. 2019 Jul;64(7):866-869. doi: 10.4187/respcare.06989. No abstract available.

    PMID: 31243162BACKGROUND

MeSH Terms

Conditions

Amyotrophic Lateral Sclerosis

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesMotor Neuron DiseaseNeurodegenerative DiseasesTDP-43 ProteinopathiesNeuromuscular DiseasesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Tiina M Andersen, PhD

    Haukeland University Hospital

    PRINCIPAL INVESTIGATOR
  • Bebiana Conde, PhD fellow

    Centro Hospitalar Tras-os-Montes e Alto Douro

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: All the subjects will receive the same intervention, and they will be examined both prior to the intervention, one month after and three months after the intervention. They will act as they own controls.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Respiratory Physiotherapist, PhD

Study Record Dates

First Submitted

March 15, 2019

First Posted

March 22, 2019

Study Start

March 21, 2019

Primary Completion

December 31, 2021

Study Completion

December 31, 2022

Last Updated

March 2, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Since the study examines patients with a rare disease in the defined geographical areas, we need to be careful not to share data that can be identifiable. A study protocol, informed consent forms and data analysis plan will be available within 6 months of study completion.

Locations